Results 231 to 240 of about 5,005,447 (264)
Some of the next articles are maybe not open access.
Tranexamic acid in hip hemiarthroplasty
Injury, 2020Intraoperative use of tranexamic acid (TXA) has been proven to reduce the administration of allogenic blood transfusion in total joint arthroplasty (TJA) patients. Data on TXA efficacy in reducing blood loss in trauma patients undergoing hip hemiarthroplasty are sparse, and its use is not yet well-established.
Itay Ashkenazi +7 more
openaire +2 more sources
Tranexamic acid in gynecologic surgery
Current Medical Research and Opinion, 2020Objective: To review the mechanism of action, pharmacology, dosing, and complications of tranexamic acid (TXA) and consolidate current evidence for TXA in gynecologic surgery.Methods: A literature search of PubMed, Ovid (MEDLINE), Google Scholar, and Elsevier was performed, in addition to a targeted search of cited references involving TXA and ...
Meir Jonathon Solnik +3 more
openaire +2 more sources
Tranexamic Acid in Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-analysis
American Journal of Sports Medicine, 2021Background: Hemarthrosis after anterior cruciate ligament (ACL) reconstruction procedures can delay rehabilitation and have toxic effects on the cartilage and synovium.
William L. Johns +5 more
semanticscholar +1 more source
BJU International, 2021
To assess the efficacy and safety of single‐dose tranexamic acid on the blood transfusion rate and outcomes of patients with complex kidney stones undergoing percutaneous nephrolithotomy (PCNL).
C. Batagello +10 more
semanticscholar +1 more source
To assess the efficacy and safety of single‐dose tranexamic acid on the blood transfusion rate and outcomes of patients with complex kidney stones undergoing percutaneous nephrolithotomy (PCNL).
C. Batagello +10 more
semanticscholar +1 more source
Tranexamic Acid for Postpartum Bleeding
Obstetric Anesthesia Digest, 2011The randomized controlled trial of the effect of tranexamic acid (TXA) on blood loss during and after cesarean delivery reported by Movafegh et al. [1] in this issue of IJGO is clinically important for two reasons. First, because hemorrhage is a serious complication of cesarean delivery and their data show that bleeding can be reduced by TXA ...
Katharine Ker, Ian Roberts
openaire +4 more sources
A Single Preoperative Dose of Tranexamic Acid Reduces Perioperative Blood Loss
Annals of Surgery, 2020Supplemental Digital Content is available in the text Objective: To review the efficacy and safety of a single dose of intravenous tranexamic acid (TXA) given preoperatively. Summary Background Data: TXA is a synthetic antifibrinolytic that has been used
M. Heyns +3 more
semanticscholar +1 more source
Journal of Cosmetic Dermatology, 2021
Treatment options for erythematotelangiectatic rosacea (ETR) are still scarce. Tranexamic acid (TXA) is an antifibrinolytic drug that was recently used for the treatment of ETR.
Najla Daadaa +7 more
semanticscholar +1 more source
Treatment options for erythematotelangiectatic rosacea (ETR) are still scarce. Tranexamic acid (TXA) is an antifibrinolytic drug that was recently used for the treatment of ETR.
Najla Daadaa +7 more
semanticscholar +1 more source
TRANEXAMIC ACID AND CORNEAL DETURGESCENCE
Acta Ophthalmologica, 1979Recent work has demonstrated decreased corneal thickness in patients with Fuch's dystrophy and in patients following cataract extraction who were given systemic tranexamic acid. Although tranexamic acid is a known antifibrinolytic drug its mechanism in reducing corneal thickness is not known.
James G. Buyer +2 more
openaire +3 more sources
Tranexamic Acid in Gastrointestinal Bleeding: A Systematic Review and Meta-Analysis
Critical Care Medicine, 2021OBJECTIVES: Tranexamic acid is proposed as a treatment for gastrointestinal bleeding. The Haemorrhage Alleviation with Tranexamic Acid-Intestinal System trial evaluated extended-use (24 hr) high-dose tranexamic acid, prompting a reappraisal for ...
J. Dionne +6 more
semanticscholar +1 more source
Journal of Maternal-Fetal & Neonatal Medicine, 2020
Background: Postpartum hemorrhage (PPH) is responsible for about 25% of maternal deaths worldwide. Antifibrinolytic agents, mainly tranexamic acid, have been demonstrated to reduce maternal blood loss and need for transfusion requirements at delivery in ...
G. Saccone +9 more
semanticscholar +1 more source
Background: Postpartum hemorrhage (PPH) is responsible for about 25% of maternal deaths worldwide. Antifibrinolytic agents, mainly tranexamic acid, have been demonstrated to reduce maternal blood loss and need for transfusion requirements at delivery in ...
G. Saccone +9 more
semanticscholar +1 more source